PYSVX
Price
$16.70
Change
-$0.77 (-4.41%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

PYSVX vs VSIAX

Header iconPYSVX vs VSIAX Comparison
Open Charts PYSVX vs VSIAXBanner chart's image
Putnam Small Cap Value Y
Price$16.70
Change-$0.77 (-4.41%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
PYSVX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PYSVX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PYSVX is a Sell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. PYSVX (289M). VSIAX pays higher dividends than PYSVX: VSIAX (2.01) vs PYSVX (0.65). PYSVX was incepted earlier than VSIAX: PYSVX (24 years) vs VSIAX (13 years). PYSVX is a more actively managed with annual turnover of: 72.00 vs. VSIAX (16.00). PYSVX has a lower initial minimum investment than VSIAX: PYSVX (500) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. PYSVX (9.05). PYSVX (53.49) and VSIAX (52.83) have equivalent 5 years return.
PYSVXVSIAXPYSVX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years13 years-
Gain YTD6.03015.03140%
Front LoadN/AN/A-
Min. Initial Investment500300017%
Min. Initial Investment IRAN/AN/A-
Net Assets289M63B0%
Annual Yield % from dividends0.652.0132%
Returns for 1 year9.0516.2356%
Returns for 3 years11.7120.6757%
Returns for 5 years53.4952.83101%
Returns for 10 years23.30105.6522%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics